Skip to main content

Health Systems Innovation Lab

The Health Systems Innovation Lab is a global research and training lab that specializes in health system performance, health policy, and venture creation.

Location

677 Huntington Ave,
Boston, MA 02115
Building 1, 11th floor

Executive Education and Professional Development

Courses

Building High-Value Health Systems: Transforming Type 1 Diabetes

Led by the Health Systems Innovation Lab at Harvard Univeristy and the Global Collaborative for Changing Diabetes in Children

About this program:

The Global Collaborative for Changing Diabetes in Children (GC-CDiC) course equips clinicians, health leaders, and innovators to transform care for children and adolescents with Type 1 Diabetes (T1D).

Eight T1D modules provide participants with the foundational skills, concepts and frameworks to critically discuss, examine, and engage in the Global T1D cohort study, high-value health systems, research ethics, epidemiology, biostatistics and data analysis, decision science, management of complex research projects, and evidence dissemination and translation.

These core modules anchor an expanding suite of applied clinical modules that draw on provider experience from GC-CDiC collaborating countries by leading clinicians. All content is designed to foster inclusive participation in, and collaboration around, the GC-CDiC global cohort study—the world’s largest longitudinal study of pediatric T1D.

Health Regulatory Senior Executive Leadership Program

Led by the University of the Witwatersrand and Harvard T.H. Chan School of Public Health

About the program

An effective regulatory framework is essential for ensuring the safety, effectiveness, and quality of medical products, improving health outcomes. The COVID-19 pandemic highlighted the need for investment in R&D, manufacturing, and regulatory capacity in Africa. A new approach is needed to build regulatory leadership within Africa. 

This program, led by the University of the Witwatersrand and Harvard T.H. Chan School of Public Health, aims to strengthen national regulatory authorities by enhancing the leadership and regulatory skills of national regulatory leaders. The African Union’s call for increased manufacturing capacity of vaccines, therapeutics, and diagnostics underscores the need for robust regulatory authorities.  

The program is part of the Future of Health and Economic Resilience of Africa (FHERA) initiative and will host in-person sessions at the University of the Witwatersrand followed by virtual mentorship for ongoing engagement. Combining the expertise of both institutions, the program aims to enhance senior executive regulatory leadership and build regional capacity for professional development. 

This is a unique moment where national, regional, and continental motivations align, offering an opportunity to support improved health regulation and ultimately enhance health outcomes across Africa.